Novocure Ltd (NVCR) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $13.75
• Market Cap: $1.68B
• EPS: $-1.61
• 52-Week High: $21.55
• 52-Week Low: $9.82

Market Sentiment

Novocure Ltd currently has a Bullish sentiment score of 0.36.

About Novocure Ltd

Novocure Ltd is a pioneering oncology company based in Saint Helier, Jersey, dedicated to transforming cancer treatment through its proprietary tumor-treating fields (TTFields) therapy, highlighted by its flagship product, Optune. This innovative approach targets and disrupts the division of cancer cells, with current approvals for specific solid tumors such as glioblastoma multiforme and mesothelioma. As Novocure enhances its clinical trial portfolio and research initiatives, it aims to soli...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Novocure Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NVCR pay dividends?

Novocure Ltd (NVCR) does not currently pay a regular dividend.

What is NVCR's market cap?

Novocure Ltd (NVCR) has a market capitalization of $1.68B with a current stock price of $13.75.